We have detected that you are using an Ad Blocker. PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
No comments yet, be the first to start the discussion!
Victor Acosta F.
brca testing, no
I don't think BRCA testing could be a game-changer in this case. I prefer Oncotype as the Er is strongly positive and the patient age is seventy. I am not sure anthracycline would be the best choice.
This patient should have complete metastatic workup with a CT Chest abdomen and pelvis and bone scan or PET/CT, due to at least stage III disease and possibility of contralateral axillary involvement. If negative, could consider neoadjuvant AC->T if excellent health and echo normal. Otherwise consider neoadjuvant TC x 6. Would not do oncotype if clinically N2 disease.
Pending Moderator approval.
Are you sure you want to delete this comment? This can't be undone.